Sun, Feb 1, 2015, 9:23 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

OncoSec Medical Incorporated Message Board

gmeabrk 2 posts  |  Last Activity: Nov 20, 2014 3:31 PM Member since: Mar 19, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Question for GME

    by bryan.paul23 Nov 19, 2014 12:30 PM
    gmeabrk gmeabrk Nov 20, 2014 3:31 PM Flag

    For what it's worth, I have no problem envisioning a 5 bagger from here. This is wound care and not cancer care. If this were a conceptual cancer drug company with zero sales and a partner in CELG, this would be trading with a stratospheric valuation, but alas, their stock in trade is wound care and infection mitigation.
    I say 400 million valuation is not unbreasonable because I continually remind myself of their lidocane patch which is clinically better and more user friendly than Lidoderm from Enzo pharma which has sales in excess of 1 billion annually. ALQA also have a functioning FDA approved manufacturing facility so it''s not like they're coming to the party without any presents... I think that it will be an interesting year for ALQA in 2015. Of course, this stock has proven me wrong on many occasions. I don't think so this time. I say parabolic if the market stays strong.

  • Perhaps now it'll start to get interesting. I've never seen a company so cleanly do the things that it's said that it's going to do. Eventually someone's going to start believing in these guys.

ONCS
0.360.00(-1.37%)Jan 30 3:58 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.